Weight and Metabolic Outcomes in Naïve HIV Patients Treated with Integrase Inhibitor-Based Antiretroviral Therapy: A Systematic Review and Meta-Analysis.
Germán Valenzuela-RodríguezCarlos Diaz-ArocutipaJaime A CollinsAdrian V HernándezPublished in: Journal of clinical medicine (2023)
In HIV patients, the use of integrase inhibitor-based therapy in comparison with protease inhibitor- or NNRTI-based therapy was associated with a small increase in weight and small decreases in lipid serum levels.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- hiv testing
- men who have sex with men
- ejection fraction
- end stage renal disease
- body mass index
- physical activity
- weight loss
- hepatitis c virus
- weight gain
- south africa
- stem cells
- body weight
- metabolic syndrome
- bone marrow
- adipose tissue
- patient reported outcomes
- type diabetes